510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1886-2013Class II

IMMULITE Systems Rapid TSH (REF LKRT1 - 100T, LKRT5 - 500 T, L2KRT2 - 200T, L2KRT6 - 600T). Intended to...

Siemens Healthcare Diagnostics Inc. / initiated 2013-05-10 / Terminated / root cause: design

Siemens Healthcare Diagnostics, Inc began a recall of IMMULITE Systems Rapid TSH (REF LKRT1 - 100T, LKRT5 - 500 T, L2KRT2 - 200T, L2KRT6 - 600T). Intended to quantitatively measure human thyroid stimulating... on . FDA classified it as Class II and gives the reason as "A rare variant of TSH, identified in a small cluster of patients, is not detected". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-1886-2013
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Siemens Healthcare Diagnostics Inc.
Product
IMMULITE Systems Rapid TSH (REF LKRT1 - 100T, LKRT5 - 500 T, L2KRT2 - 200T, L2KRT6 - 600T). Intended to quantitatively measure human thyroid stimulating hormone (TSH, thyrotropin).
Product code
JLW Radioimmunoassay, Thyroid-Stimulating Hormone
Reason for recall
A rare variant of TSH, identified in a small cluster of patients, is not detected.
Root cause tag
design
FDA root cause
Device Design
Action
On May 10, 2013, an Important Safety Information notice was sent to all affected Siemens Healthcare Diagnostic customers in the United States. On May 10, 2013, an Urgent Field Safety Notice was sent to all customers outside of the United States. These notices inform the customer that there is a rare variant of TSH, identified in a small cluster of patients that is not detected by some Siemens assays. This notice informs customers that they should continue to use the affected TSH assays as the observed rate of occurrence during a 30-month time period was 0.6 X 10 -7 and there are strong mitigating factors. These mitigating factors include co-interpretation of TSH results in conjunction with thyroxine and TS, patient history and clinical signs and symptoms. Although Siemens believes a look back is not required as the expected frequency of the variant is extremely rare, these notices state that this decision should be made by the medical director.
Quantity in commerce
13462
Distribution
Worldwide Distribution-USA (nationwide) and the countries of Canada, AE, AR, AT, AU, BA, BD, BE, BG, BO, BR, BY, CH, CL, CM, CN, CO, CR, CY, CZ, DE, DK, DO, DZ, EC, EE, EG, ES, FI, FR, GB, GR, GT, HK, HN, HR, HU, ID, IE, IL, IN, IR, IS, IT, JO, JP, KA, KR, KW, KZ, LB, LK, LT, LV, LY, MA, MK, MT, MX, MY, NI, NL, NO, NP, OM, PA, PE, PH, PK, PL, PT, PY, QA, RO, RU, SA, SE, SG, SK, SV, SY, TH, TM, TN, TR, TW, UA, UY, UZ, VE, VN, XS, and ZA.
Product codes and lots
Per recall strategy.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1886-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1881-2013Class IITerminatedVoluntary: Firm initiated
Z-1882-2013Class IITerminatedVoluntary: Firm initiated
Z-1883-2013Class IITerminatedVoluntary: Firm initiated
Z-1884-2013Class IITerminatedVoluntary: Firm initiated
Z-1885-2013Class IITerminatedVoluntary: Firm initiated
Z-1886-2013Class IITerminatedVoluntary: Firm initiated